Who is sponsoring NCT03831516?

NCT03831516 is sponsored by Northwell Health.

What drugs are being tested in NCT03831516?

Interventions in NCT03831516: Non Invasive Electroanatomical Mapping.

What condition does NCT03831516 study?

NCT03831516 studies Premature Ventricular Complex, Ventricular Arrythmia.

Is NCT03831516 still recruiting?

NCT03831516 is currently completed. Last updated 20 April 2022.

Last reviewed 2022-04-20 · How we verify

NCT03831516

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias

Completed Last updated 20 April 2022

What this trial tests

trial testing Non Invasive Electroanatomical Mapping in Premature Ventricular Complex in 30 participants. Completed in 1 March 2022.

Timeline

4 January 2019

Primary endpoint
1 March 2022

1 March 2022

Quick facts

Lead sponsor	Northwell Health
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	4 January 2019
Primary completion	1 March 2022
Estimated completion	1 March 2022
Sites	1 location across United States

Drugs / interventions tested

Non Invasive Electroanatomical Mapping

Conditions studied

Premature Ventricular Complex — all drugs for Premature Ventricular Complex →
Ventricular Arrythmia — all drugs for Ventricular Arrythmia →

Sponsor

Northwell Health — full company profile →

Who can join

18 and older, any sex, with Premature Ventricular Complex or Ventricular Arrythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will measure the diagnostic sensitivity and specificity of the Medtronic CardioInsight wearable 252 electrode vest in predicting the chamber of origin of premature ventricular complexes (PVCs) and compare its diagnostic accuracy with the standard 12- lead ECG.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Northwell Health trials

Trials by the same sponsor.

NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03831516 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwell Health
Last refreshed: 20 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03831516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing